北京桀亚莱福生物技术有限责任公司
Beijing Jayyalife Biological Technology Co.,Ltd.
产品销售热线:
首页 > Allograft (Alloderm) and autograft (temporalis fas

Allograft (Alloderm) and autograft (temporalis fas

    发布时间:[2014-06-05]

     

    Allograft (Alloderm) and autograft (temporalis fascia) implantation for glottic insufficiency: a novel approach.
    Tan M, Bassiri-Tehrani M, Woo P.
    Source
    The Department of Otolaryngology Head and Neck Surgery, Mount Sinai School of Medicine, New York, New York 10029, USA. melintangeller@gmail.com
    Abstract
    OBJECTIVE: 
    Traditionally, glottic insufficiency because of scar, atrophy, and sulcus has been treated by injection or medialization laryngoplasty. These procedures do not reestablish the vertical height of the vocal fold margin. We propose soft tissue augmentation laryngoplasty with allograft (sheet Alloderm; LifeCell Corporation, Branchburg, NJ) or autograft (temporalis fascia) via a minithyrotomy or a transoral approach.
    STUDY DESIGN: 
    A retrospective case series analysis of 21 patients treated by sheet Alloderm or temporalis fascia for correction of glottic insufficiency.
    METHODS: 
    Twenty-one patients with glottic insufficiency secondary to scar, atrophy, or sulcus were treated. Ten failed prior techniques. Seventeen had minithyrotomy by a small fenestration in the thyroid cartilage. Exploration of scar or lamina propria through the fenestration allowed for the creation of a pocket for Alloderm implantation within the intermediate layer of the lamina propria. Four patients underwent a transoral approach by cordotomy with either Alloderm or temporalis fascia implantation, which also allowed for exploration of scar but required repair using sutures. These implantation approaches allowed for both restoration of the layered structure and augmentation of the middle third of the musculomembranous vocal fold. Preoperative and postoperative videostroboscopic examinations were reviewed with review of clinical outcome.
    RESULTS: 
    With a median follow-up time of 12 months, patients demonstrated excellent long-term vocal fold augmentation and minimal absorption of the implant in 19 out of 21 patients. There is improved pliability of the vocal fold with good oscillation in scar patients.
    CONCLUSION: 
    Minithyrotomy with soft tissue augmentation is a novel approach for soft tissue augmentation of glottic insufficiency. It has the advantage of augmentation of the medial edge of the vocal fold with a soft tissue implant that has long-term viability. Its role should be explored further in patients with atrophy and scar.
    Copyright © 2011 The Voice Foundation. Published by Mosby, Inc. All rights reserved.
    Acta Otolaryngol. 2010 Nov;130(11):1293-9.
     

Copyright北京桀亚莱福生物技术有限责任公司版权所有 京ICP备:19019223号 (旧版入口)

企业邮箱:jayyalife@jayyalife.net 技术支持:010-60524207-8006